Browse > Article
http://dx.doi.org/10.3839/jabc.2020.013

Improving effect of psoriasis dermatitis by yakuchinone A in the TNF-α stimulated HaCaT cells  

Kim, Min Young (School of Cosmetic Science and Beauty Biotechnology, Semyung University)
Hwang, Hyung Seo (School of Cosmetic Science and Beauty Biotechnology, Semyung University)
Publication Information
Journal of Applied Biological Chemistry / v.63, no.1, 2020 , pp. 95-101 More about this Journal
Abstract
Psoriasis is an autoimmune skin disease that is accompanied by hyper proliferation of the epidermis, erythema of various sizes, and ulceration. However, the mechanism of the development of psoriasis dermatitis is unclear. Recently, it is known that the inflammatory cytokines and Th17 cells as well as chemokine (CC motif) ligand 20 (CCL20) are involved in the process of keratinocytes hyper-differentiation, which is common in psoriasis dermatitis. Therefore, we studied the effects of yakuchinone-A, an active ingredient of Alpinia oxyphylla Miquel known for its anti-inflammatory activity, to improve psoriasis dermatitis. First, cytotoxicity of yakuchinone-A was observed in cell counting kit-8 assay and not observed in 10 ㎍/mL concentration on the human keratinocyte HaCaT cells. Yakuchinone-A in the presence of tumor necrosis factor-alpha (TNF-α) on HaCaT cells inhibited mRNA expression of IL-6, IL-8, and TNF-α by up to 61.4±7.5, 23.6±1.5, 46.0±4.8%. CCL20, a chemokine that attracts immune cells such Th17 cells to the inflammation location, was also significantly suppressed by yakuchinone-A. In addition, IκB and STAT3 phosphorylation involved in the CCL20 expression was inhibited by yakuchinone-A in a concentration-dependent manner up to the level of 79.1±5.0, 80.8±2.3%. Furthermore, yakuchinone-A downregulated CCL20 mRNA expression level on IL-17A-activated HaCaT cells as a concentration-dependent manner. Based on these results, yakuchinone-A is expected to be developed as a new material for improving psoriasis dermatitis in the future.
Keywords
Alpiniaoxy phyla Miquel; Anti-inflammation; Chemokine (C-C motif) ligand 20; Keratinocyte; Psoriasis; Yakuchinone-A;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Chun KS, Kang JY, Kim OH, Kang H, Surh YJ (2002) Effects of yakuchinone A and yakuchinone B on the Phorbol ester-induced expression of COX-2 and iNOS and activation of $NF-{\kappa}B$ in mouse skin. J Environ Pathol Tox. doi: 10.1615/JenvironPatholToxicolOncol.v21.i2.60
2 Jang S, Jung JC, Oh S (2007) Synthesis of 1, 3-diphenyl-2-propen-1-one derivatives and evaluation of their biological activities. Bioorgan Med Chem 15: 4098-4105   DOI
3 Huang KK, Lin MN, Hsu YL, Lu I, Pan I, Yang JL (2019) Alpiniaoxyphylla Fruit Extract Ameliorates Experimental Autoimmune Encephalomyelitis through the Regulation of Th1/Th17 Cells. Evid Based Compl Alt. doi: 10.1155/2019/6797030
4 Choi DH, Hwang HS (2019) Anti-inflammation activity of brazilin in $TNF-{\alpha}$ induced human psoriasis dermatitis skin model. Appl Biol Chem. Doi: 10.1186/s137650190455z
5 Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M (1997) The $I{\kappa}B$ kinase complex (IKK) contains two kinase subunits, $IKK{\alpha}$ and $IKK{\beta}$, necessary for $I{\kappa}B$ phosphorylation and $NF-{\kappa}B$ activation. Cell 91: 243-252   DOI
6 Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25: 821-852   DOI
7 Mease PJ (2002) Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis 61: 298-304   DOI
8 Ullah A, Johora FT, Sarkar B, Araf Y, Rahman H (2020) Curcumin analogues as the inhibitors of TLR4 pathway in inflammation and their drug like potentialities: A computer-based study. bioRxiv. doi: 10.1101/2020.01.27.921528
9 Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol 31: 205-212   DOI
10 Choi YM, Wu JJ (2015) Trends in the Frequency of Original Research in Acne Vulgaris, Rosacea, Dermatitis, Psoriasis, Skin Cancer, and Skin Infections, 1970-2010. Perm J 19: 44-47   DOI
11 Liu Y, Lagowski JP, Gao S, Raymond JH, White CR, Kulesz-Martin MK (2010) Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes. J Eur Acad Dermatol 130: 1384-1390
12 Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Lordanov M, Blauvelt A (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129: 2175-2183   DOI
13 Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9: 461-467   DOI
14 Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, AkIhicoY, Hennighausen L, O'Shea JJ (2006) Selective regulatory function of Socs 3 in the formation of IL-17-secreting T cells. P Natl Acad Sci USA 103: 8137-8142   DOI
15 Stockinger B, Veldhoen M (2007) Differentiation and function of Th17 T cells. Curr Opin Immunol 19: 281-286   DOI
16 Kao CY, Huang F, Chen Y, Thai P, Wachi S, Kim C, Tam L, Wu R (2005) Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/$NF-{\kappa}B$-dependent signaling pathway. J Immunol 175: 6676-6685   DOI
17 Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF, Brusselle GG (2007) Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Resp Crit Care 175: 998-1005   DOI
18 Homey B, DieuNosjean MC, Wiesenborn A, Massacrier C, Pin JJ, Oldham E, Catron D, Buchanan ME, Muller A, Malefyt RD, Orozco R, Ruzicka T, Lehmann P, Lebecque S, CauxC, Zlotnik A, Deng G (2000) Up-regulation of macrophage inflammatory protein-$3{\alpha}$/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164: 6621-6632   DOI
19 Hirata T, Osuga Y, Takamura M, Kodama A, Hirota Y, Koga K, Yoshino O, Harada M, Yano T, Taketani Y (2010) Recruitment of CCR6- expressing Th17 cells by CCL 20 secreted from $IL-1{\beta}$-, $TNF-{\alpha}$-, and IL-17A-stimulated endometriotic stromal cells. Endocrinology 151: 5468-5476   DOI
20 Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B, Graziadei I, Dunzendorfer S, Wiedermann CJ, Murzl E, Jasarevic Z, Romani N, Offner FA, Tilg H, Grasl E (2004) Increased expression of CCL20 in human inflammatory bowel disease. J ClinImmunol 24: 74-85
21 Tzu J, Kerdel F (2008) From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Dermatol Ther 21: 131-141   DOI
22 Chang YM, Tsai CT, Wang CCR, Chen YS, Lin YM, Kuo CH, Tzang BS, Chen RJ, Tsai FT, Huang CY (2013) Alpinateoxyphyllaefructus (AlpiniaOxyphyllaMiq) extracts inhibit angiotensin-II induced cardiac apoptosis in H9c2 cardiomyoblast cells. Biosci Biotech Bioch 77: 229-234   DOI
23 Liu A, Zhao X, Li H, Liu Z, Liu B, Mao X, Guo L, Bi K, Jia Y (2014) 5-Hydroxymethylfurfural, an antioxidant agent from AlpiniaoxyphyllaMiq. improves cognitive impairment in $A{\beta}1$-42 mouse model of Alzheimer's disease. Int Immunopharmacol 23: 719-725   DOI
24 Qing ZJ, Yong W, Hui LY, Yong LW, Long LH, Ao DJ, Xia PL (2012) Two new natural products from the fruits of Alpiniaoxyphylla with inhibitory effects on nitric oxide production in lipopolysaccharideactivated RAW264.7 macrophage cells. Arch Pharm Res 35: 2143-2146   DOI
25 Lin RJ, Yen CM, Chou TH, Chiang FY, Wang GH, Tseng YP, Wang L, Huang TW, Wang HC, Chan LP, Liang CH, Ding HY (2013) Antioxidant, anti-adipocyte differentiation, antitumor activity and anthelminticactivities against Anisakis simplex and Hymenolepis nana ofyakuchinone A from Alpiniaoxyphylla. BMC Complem Altern M. dio: 10.1186/1472688213237
26 Lee E, Park KK, Lee JM, Chun KS, Kang JY, Lee SS, Suerh YJ (1998) Suppression of mouse skin tumor promotion and induction of apoptosis in HL-60 cells by AlpiniaoxyphyllaMiquel (Zingiberaceae). Carcinogenesis 19: 1377-1381   DOI
27 Yu X, An L, Wang Y, Zhao H, Gao C (2003) Neuroprotective effect of AlpiniaoxyphyllaMiq.fruits against glutamate-induced apoptosis in cortical neurons. Toxicol Lett 144: 205-212   DOI
28 Chang YM, Chang HH, Tsai CC, Lin HJ, Ho TJ, Ye CX, Chiu LP, Chen YS, Chen RJ, Huang CY, Lin CC (2017) AlpiniaoxyphyllaMiq.fruit extract activates IGFR-PI3K/Akt signaling to induce Schwann cell proliferation and sciatic nerve regeneration. BMC Complem Altern M. doi: 10.1186/s1290601716952
29 Choi DH, Kim MR, Kim MY, Kim HH, Park SY, Hwang HS (2019) Studies on Antioxidant, Anti-inflammatory and Whitening Effects of Oriental Herbal Extracts (Mix) including Eucommiae cortex. J Soc Cosmet Scientists Korea 45: 37-47   DOI
30 Flynn DL, Rafferty MF, Boctor AM (1986) Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prosta Leukotr Med 22: 357-360   DOI